Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021

The aim of this review is to update the current status of allogeneic hemopoietic stem cell transplants (HSCT) for patients with myelofibrosis (MF). We have first summarized the issue of an indication for allogeneic HSCT, discussing several prognostic scoring systems, developed to predict the outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacigalupo, Andrea, Innocenti, Idanna, Rossi, Elena, Sora, Federica, Galli, Eugenio, Autore, Francesco, Metafuni, Elisabetta, Chiusolo, Patrizia, Giammarco, Sabrina, Laurenti, Luca, Benintende, Giulia, Sica, Simona, De Stefano, Valerio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129535/
https://www.ncbi.nlm.nih.gov/pubmed/34017327
http://dx.doi.org/10.3389/fimmu.2021.637512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129535/
https://www.ncbi.nlm.nih.gov/pubmed/34017327
http://dx.doi.org/10.3389/fimmu.2021.637512

Ejemplares similares